Jubilant Life Sciences appoints Dr Syed Kazmi as president and CEO in US
Jubilant Life Sciences Limited has announced that Dr. Syed Kazmi, PhD, MBA, will join its new innovative biopharmaceutical company in the US, Jubilant Therapeutics Inc, as president and chief executive officer.
Dr. Kazmi joins from Novartis Pharmaceuticals Corporation, where he was vice president, global head of business development & licensing for oncology.
Shyam Bhartia and Hari Bhartia, chairman and co-chairman of Jubilant Life Sciences said, Syed has had an accomplished career of over 25 years in M&A, licensing, strategic collaborations, and R&D in both specialty biotech and large pharma companies. We are confident that his extensive experience will help make Jubilant Therapeutics a successful global clinical stage biopharmaceutical company with the mission of transforming the lives of patients with serious diseases.